| Financial Year |
March 31 2023 |
| Monetary Funds |
16,072,839,823.50 |
| Held-for-trading Financial Assets |
1,253,251.23 |
| Notes Receivable |
615,088,968.63 |
| Accounts Receivable |
38,497,869,039.05 |
| Advances to Suppliers |
4,946,579,152.30 |
| Other Receivables |
5,452,114,022.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,155,696.85 |
| Inventories |
12,967,145,706.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
59,624,782.57 |
| Other Current Assets |
3,788,092,572.62 |
| Total Current Assets |
135,631,015,495.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,371,958,939.53 |
| Long-term Equity Investment |
2,956,554,024.76 |
| Investment Properties |
310,304,151.98 |
| Fixed Assetes |
5,431,538,894.86 |
| Under-construction Projects |
675,414,434.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,804,152,971.47 |
| R&D expenses |
8,757,499.67 |
| Goodwill |
9,670,879.14 |
| Long-Term Deferred and Prepaid Expenses |
98,344,304.27 |
| Deferred Income Tax Assets |
1,802,724,858.66 |
| Other Non-Current Assets |
1,087,907,847.55 |
| Sub-Total of Non-Current Assets |
69,570,473,229.97 |
| Total Assets |
205,201,488,725.29 |
| Short-Term Loans |
22,731,500,970.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,406,525,765.79 |
| Accounts Payable |
45,182,277,446.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
943,258,253.11 |
| Taxes Payable |
1,134,663,968.19 |
| Interest Payable |
-- |
| Dividend Payable |
120,013,295.99 |
| Other payables |
7,692,148,913.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,706,164,073.02 |
| Other Current Liabilities |
15,176,230,701.31 |
| Sub-Total of Current Liabilities |
126,884,821,863.67 |
| Long-term Loans |
35,253,452,151.12 |
| Bonds Payable |
3,545,904,260.37 |
| Long-Term Accounts Payable |
2,597,786,879.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
29,703,458.64 |
| Deferred Income Tax Liabilities |
97,517,024.96 |
| Other Non-Current Liabilities |
180,000,000.00 |
| Sub-Total of Non-Current Liabilities |
42,307,606,010.22 |
| Total Liabilities |
169,192,427,873.89 |
| Paid-In Capital(Or Share Stock) |
3,019,714,428.00 |
| Capital Surplus |
3,894,933,862.92 |
| Surplus Reserve |
312,780,956.42 |
| LESS:Treasury Stock |
67,607,923.62 |
| Undistributed Profits |
9,330,582,942.83 |
| Minority Stockholder's Interest |
10,246,955,206.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,762,105,644.85 |
| Owner's Equity（Stockholder's Equity） |
36,009,060,851.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
205,201,488,725.29 |
